Chuanliang Cui

机构：Ministry of Education · ORCID：0000-0001-6455-0843

发表论文 295 篇 · 总被引 6572 次 · h-index 39

代表论文

• Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial (2024 · Signal Transduction and Targeted Therapy · 被引 38)
• Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights (2025 · Journal for ImmunoTherapy of Cancer · 被引 22)
• Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study (2025 · Med · 被引 16)
• Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial (2024 · Journal for ImmunoTherapy of Cancer · 被引 14)
• SAFFRON-103: A Phase Ib Study of Sitravatinib Plus Tislelizumab in Anti-PD-(L)1 Refractory/Resistant Advanced Melanoma (2024 · Immunotherapy · 被引 9)
• Dynamic Change of PD‐L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti‐PD‐1 Therapy (2025 · Journal of Extracellular Vesicles · 被引 8)